Consumer Preferences in Therapeutic Respiratory Devices Market By 2023 to 2033

BySanket Badgujar
Therapeutic Respiratory Devices Market

The global therapeutic respiratory devices market is anticipated to witness exponential growth, estimated to attain a market value of US$ 50.6 billion in 2023, and projected to reach an impressive US$ 80.2 billion by 2033, reflecting a robust Compound Annual Growth Rate (CAGR) of 4.7%. This forecast, detailed in a recent market analysis report, underscores the escalating demand for advanced respiratory solutions amid the rising prevalence of respiratory diseases worldwide.

The surge in respiratory ailments such as Chronic Obstructive Pulmonary Disease (COPD) and sleep apnea has been a pivotal driver behind the market’s anticipated growth trajectory. This escalating trend has prompted an increased need for therapeutic respiratory devices designed to alleviate and manage these conditions effectively.

Discover Our Expert Analysis with Our Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-14374

The product landscape of the therapeutic respiratory devices market encompasses a wide range of devices, including inhalers, nebulizers, ventilators, continuous positive airway pressure (CPAP) machines, and oxygen concentrators. These devices are utilized in various settings, including hospitals, clinics, home care, and ambulatory care centers.

As governments and healthcare organizations across the globe strive to improve healthcare infrastructure, access to medical facilities, and patient outcomes, the demand for therapeutic respiratory devices is expected to continue rising. Additionally, the COVID-19 pandemic has highlighted the importance of respiratory support devices, resulting in increased investments in research and development to introduce more advanced and effective solutions.

Key Takeaways:

  • Existence of modern healthcare facilities in the United States and Canada, the therapeutic respiratory devices market in North America gained over 36% market share in 2021.
  • The Asia Pacific is predicted to expand the quickest throughout the forecast period, owing to factors such as increased asthma incidence in adults and children, as well as technology improvements.
  • Additionally, the market expansion would be aided by rising healthcare awareness and improved healthcare infrastructure.
  • The clinical trial of Tempol for the treatment of COVID-19 by Adams Respiratory Therapeutics Inc has surpassed enrollment expectations.
  • COPD is estimated to affect 10% of adults aged 75 and older in the United States, according to the Journal of the Italian Society of Gerontology and Geriatrics.
  • According to statistics issued by the Global Initiative for Asthma (GINA), an estimated 100 million people with asthma are expected to be diagnosed by 2025.

Competitive Landscape:

  • Aerin Medical
  • BMC Medical Co., Ltd.
  • CareFusion Corporation
  • Covidien Plc
  • Drägerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Limited
  • GE Healthcare
  • Hamilton Medical
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Medtronic
  • Nidek Medical Products, Inc.
  • Teleflex Incorporated
  • Smiths Medical

Acquisitions and mergers, the launch of new products and services, partnerships and joint ventures, MoU agreements, V.C. and funding activities, R&D activities, and geographic expansion, among other noteworthy activities by key players in the therapeutic respiratory devices market, are among the key strategic developments in the competitive landscape.

  • Acapella, a select blue vibratory PAP therapy device, was released by Smiths Medical in April 2021. It is a drug-free supplementary therapy for people with asthma, COPD, cystic fibrosis, and lung illness that aids in the evacuation of secretions.
  • Koninklijke Philips N.V. finalized the acquisition of BioTelemetry, Inc., a firm located in the United States, in February 2021. This aided in the expansion of Philips’ product line, resulting in increased sales of therapeutic respiratory devices.

Key Segments:

By Product:

  • Positive Airway Pressure (PAP) Devices
    • Continuous Positive Airway Pressure (CPAP) Devices
    • Auto-titrating Positive Airway Pressure (APAP) Devices
    • Bi-level Positive Airway Pressure (BiPAP) Devices
  • Oxygen Concentrator
    • Fixed Oxygen Concentrators
    • Portable Oxygen Concentrators
  • Ventilators
    • Adult Ventilators
    • Neonatal Ventilators
  • Inhalers
    • Metered Dose Inhaler (MDI)
    • Dry Powder Inhaler (DPI)
    • Soft Mist Inhaler (SMI)
  • Nebulizers
    • Compressor-based Nebulizers
    • Piston-based Hand-held Nebulizers
    • Ultrasonic Nebulizers
  • Humidifiers
    • Heated Humidifiers
    • Passover Humidifiers
    • Integrated Humidifiers
    • Built-in Humidifiers
    • Standalone Humidifiers
  • Others

By Application:

  • COPD
  • Obstructive Sleep Apnea
  • Asthma
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Others

By End-use:

  • Hospital
  • Homecare Settings
  • Emergency Centers